|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||69.35 / 89.27|
In one scenario, we crack these levels and then come back and retest on the pullback.
We'll sell our remaining shares in Panera and Costco to protect profits and move on.
Four women serve on the boards of four S&P 500 companies at the same time.
More than a dozen people sit on the four boards for components of the S&P 500, of which four are women.
The company discusses potential share repurchases and its acquisition strategy.
With Macy's, Walmart and other retailers reporting this week, steel yourself for the bad news.
The continuous glucose monitor maker is an excellent growth opportunity.
The most ethnically and gender diverse boards may surprise you.
While breadth has faltered, it has not weakened.
The Treasury Department's move to ease sanctions on Russian intelligence agency FSB was good news for Russia ETFs -- and U.S. exporters.
Here's how to use charts to trade five stocks, including Dow Chemical and Honeywell.
Some of Wall Street's biggest stocks are teetering on the edge of breakout territory this week. Here are five of them.
Jim Cramer highlights bank, health-care companies reporting next week and what to watch.
Dividend growers Texas Instruments, Accenture and Medtronic are superior to companies that simply sport high dividend yields, says one portfolio manager.
An attempt to repeal the Affordable Care Act and the brewing policy war between President-elect Donald Trump and the Democrats won't slow these three health sector juggernauts.
Sirius, Medtronic and Carlyle could be money makers in 2017, says Jim Cramer.
Jim Cramer outlines what he thinks this market needs to keep the Trump rally rolling in 2017.
Here are Tuesday's top research calls, including downgrades for Medtronic, Nokia and Paccar, and an upgrade for Verizon.
While most investors fixate on Dow 20,000, breakouts are already happening in the individual stocks.
Here's a look at the 10 best dividend stocks to invest in for potential outperformance in 2017.
Insiders at these companies -- including Medtronic and Medicines -- have been scooping up shares of their own stock lately.
Just like cloud computing drove Amazon, AI should do the same for Big Blue.
As the dominant player in the transcatheter aortic valve replacement market, Edwards doesn't 'need' large deals.
Broadcom released better-than-expected 2016 fourth-quarter results, and its stock on Friday is giving a picture of where the rally could 'broaden to,' says Jim Cramer.